Pluri Inc. announced that it has appointed industry expert, Andy Lewin, to lead the business of its Contract Development and Manufacturing Organization (CDMO): PluriCDMO division. Mr. Lewin brings 25 years of commercial leadership experience within the CDMO sector in global companies including Ascend Gene and Cell Therapies Ltd., Oxford Biomedica, and AGC Biologics Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.357 USD | +9.33% | +2.04% | +15.55% |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Apr. 08 | Sector Update: Health Care | MT |
1st Jan change | Capi. | |
---|---|---|
+15.55% | 27.91M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PLUR Stock
- News Pluri Inc.
- Pluri Inc. Appoints Andy Lewin to Lead Business of its Contract Development and Manufacturing Organization: PluriCDMO Division